These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 10858196

  • 1. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.
    Dadaglio G, Moukrim Z, Lo-Man R, Sheshko V, Sebo P, Leclerc C.
    Infect Immun; 2000 Jul; 68(7):3867-72. PubMed ID: 10858196
    [Abstract] [Full Text] [Related]

  • 2. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.
    Fayolle C, Osickova A, Osicka R, Henry T, Rojas MJ, Saron MF, Sebo P, Leclerc C.
    J Virol; 2001 Aug; 75(16):7330-8. PubMed ID: 11462005
    [Abstract] [Full Text] [Related]

  • 3. Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites.
    Osicka R, Osicková A, Basar T, Guermonprez P, Rojas M, Leclerc C, Sebo P.
    Infect Immun; 2000 Jan; 68(1):247-56. PubMed ID: 10603395
    [Abstract] [Full Text] [Related]

  • 4. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus.
    Saron MF, Fayolle C, Sebo P, Ladant D, Ullmann A, Leclerc C.
    Proc Natl Acad Sci U S A; 1997 Apr 01; 94(7):3314-9. PubMed ID: 9096390
    [Abstract] [Full Text] [Related]

  • 5. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes.
    Fayolle C, Sebo P, Ladant D, Ullmann A, Leclerc C.
    J Immunol; 1996 Jun 15; 156(12):4697-706. PubMed ID: 8648115
    [Abstract] [Full Text] [Related]

  • 6. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.
    Fayolle C, Ladant D, Karimova G, Ullmann A, Leclerc C.
    J Immunol; 1999 Apr 01; 162(7):4157-62. PubMed ID: 10201941
    [Abstract] [Full Text] [Related]

  • 7. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L, Fayolle C, Bauche C, Ladant D, Leclerc C.
    J Virol; 2005 Aug 01; 79(15):9872-84. PubMed ID: 16014948
    [Abstract] [Full Text] [Related]

  • 8. Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells.
    Sebo P, Fayolle C, d'Andria O, Ladant D, Leclerc C, Ullmann A.
    Infect Immun; 1995 Oct 01; 63(10):3851-7. PubMed ID: 7558291
    [Abstract] [Full Text] [Related]

  • 9. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells.
    Karimova G, Fayolle C, Gmira S, Ullmann A, Leclerc C, Ladant D.
    Proc Natl Acad Sci U S A; 1998 Oct 13; 95(21):12532-7. PubMed ID: 9770520
    [Abstract] [Full Text] [Related]

  • 10. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
    Dadaglio G, Morel S, Bauche C, Moukrim Z, Lemonnier FA, Van Den Eynde BJ, Ladant D, Leclerc C.
    Int Immunol; 2003 Dec 13; 15(12):1423-30. PubMed ID: 14645151
    [Abstract] [Full Text] [Related]

  • 11. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying multiple copies of a viral CD8(+) T-cell epitope.
    Sebo P, Moukrim Z, Kalhous M, Schaft N, Dadaglio G, Sheshko V, Fayolle C, Leclerc C.
    FEMS Immunol Med Microbiol; 1999 Nov 13; 26(2):167-73. PubMed ID: 10536304
    [Abstract] [Full Text] [Related]

  • 12. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
    Schlecht G, Loucka J, Najar H, Sebo P, Leclerc C.
    J Immunol; 2004 Nov 15; 173(10):6089-97. PubMed ID: 15528345
    [Abstract] [Full Text] [Related]

  • 13. Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.
    Préville X, Ladant D, Timmerman B, Leclerc C.
    Cancer Res; 2005 Jan 15; 65(2):641-9. PubMed ID: 15695409
    [Abstract] [Full Text] [Related]

  • 14. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L, Simsova M, Jarvis Z, Brodin P, Rojas MJ, Bauche C, Nouzé C, Ladant D, Cole ST, Sebo P, Leclerc C.
    Infect Immun; 2006 Apr 15; 74(4):2128-37. PubMed ID: 16552042
    [Abstract] [Full Text] [Related]

  • 15. Delivery of a MalE CD4(+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase.
    Loucká J, Schlecht G, Vodolánová J, Leclerc C, Sebo P.
    Infect Immun; 2002 Feb 15; 70(2):1002-5. PubMed ID: 11796640
    [Abstract] [Full Text] [Related]

  • 16. Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids.
    Wilkinson KA, Simsova M, Schölvinck E, Sebo P, Leclerc C, Vordermeier HM, Dickson SJ, Brown JR, Davidson RN, Pasvol G, Levin M, Wilkinson RJ.
    Infect Immun; 2005 May 15; 73(5):2991-8. PubMed ID: 15845506
    [Abstract] [Full Text] [Related]

  • 17. Characterization of recombinant Bordetella pertussis adenylate cyclase toxins carrying passenger proteins.
    Gmira S, Karimova G, Ladant D.
    Res Microbiol; 2001 Dec 15; 152(10):889-900. PubMed ID: 11766964
    [Abstract] [Full Text] [Related]

  • 18. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.
    Lee SJ, Gray MC, Guo L, Sebo P, Hewlett EL.
    Infect Immun; 1999 May 15; 67(5):2090-5. PubMed ID: 10225859
    [Abstract] [Full Text] [Related]

  • 19. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
    Fayolle C, Bauche C, Ladant D, Leclerc C.
    Vaccine; 2004 Dec 16; 23(5):604-14. PubMed ID: 15542180
    [Abstract] [Full Text] [Related]

  • 20. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S, Kamanova J, Simsova M, Sebo P, Bolte S, Heussler V, Fleischer B, Jacobs T.
    Infect Immun; 2006 Apr 16; 74(4):2277-85. PubMed ID: 16552058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.